Fidelity Investments’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$301M Buy
15,379,377
+994,921
+7% +$29.5M 0.02% 690
2025
Q4
$448M Buy
14,384,456
+2,135,101
+17% +$58.6M 0.02% 554
2025
Q3
$264M Buy
12,249,355
+10,552
+0.1% +$190K 0.01% 738
2025
Q2
$171M Buy
12,238,803
+15,817
+0.1% +$215K 0.01% 885
2025
Q1
$165M Buy
12,222,986
+341,074
+3% +$5.81M 0.01% 881
2024
Q4
$228M Buy
11,881,912
+698,434
+6% +$15.2M 0.01% 767
2024
Q3
$254M Buy
11,183,478
+1,610,130
+17% +$26.3M 0.02% 738
2024
Q2
$125M Buy
9,573,348
+158,213
+2% +$2.19M 0.01% 969
2024
Q1
$165M Buy
9,415,135
+1,789,593
+23% +$34.7M 0.01% 867
2023
Q4
$166M Buy
7,625,542
+7,363,354
+2,808% +$116M 0.01% 821
2023
Q3
$4.02M Buy
262,188
+429
+0.2% +$8.18K ﹤0.01% 2106
2023
Q2
$6.23M Buy
261,759
+117,611
+82% +$3.02M ﹤0.01% 2001
2023
Q1
$3.67M Buy
144,148
+142,950
+11,932% +$4.58M ﹤0.01% 2188
2022
Q4
$35K Buy
1,198
+755
+170% +$17.4K ﹤0.01% 3563
2022
Q3
$9K Buy
443
+374
+542% +$6.72K ﹤0.01% 4132
2022
Q2
$1K Buy
+69
New +$927 ﹤0.01% 4817
2020
Q4
Sell
-259,244
Closed -$3.01M 4323
2020
Q3
$3.01M Hold
259,244
﹤0.01% 2205
2020
Q2
$4.32M Hold
259,244
﹤0.01% 2095
2020
Q1
$1.74M Buy
259,244
+66,667
+35% +$776K ﹤0.01% 2226
2019
Q4
$1.39M Hold
192,577
﹤0.01% 2346
2019
Q3
$2.11M Hold
192,577
﹤0.01% 2257
2019
Q2
$5.92M Hold
192,577
﹤0.01% 2045
2019
Q1
$8.06M Hold
192,577
﹤0.01% 1937
2018
Q4
$8.75M Sell
192,577
-63,295
-25% -$3.66M ﹤0.01% 1846
2018
Q3
$21.4M Sell
255,872
-32,987
-11% -$3.11M ﹤0.01% 1651
2018
Q2
$27.8M Hold
288,859
﹤0.01% 1556
2018
Q1
$30.4M Buy
288,859
+80,533
+39% +$8.75M ﹤0.01% 1524
2017
Q4
$32.6M Hold
208,326
﹤0.01% 1492
2017
Q3
$28.6M Hold
208,326
﹤0.01% 1561
2017
Q2
$40.4M Hold
208,326
0.01% 1378
2017
Q1
$38.9M Buy
+208,326
New +$35.9M ﹤0.01% 1440

Other funds holding VRDN